ACETYL- L- CARNITINE ( DrugBank: Carnitine )


1 disease
IDDisease name (Link within this page)Number of trials
265Lipodystrophy1

265. Lipodystrophy


Clinical trials : 116 Drugs : 170 - (DrugBank : 61) / Drug target genes : 26 - Drug target pathways : 97
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-004665-42-IT
(EUCTR)
17/03/200621/04/2006Evaluation of the efficacy and tollerability of long-term somministration of Acetyl-l-carnitine in the treatment of HIV related lipodystrophy.Parallel group, randomized, double blind, controlled versus placebo study. - NDEvaluation of the efficacy and tollerability of long-term somministration of Acetyl-l-carnitine in the treatment of HIV related lipodystrophy.Parallel group, randomized, double blind, controlled versus placebo study. - ND HIV related LIPODYSTROPHY.
MedDRA version: 6.1;Level: PT;Classification code 10061624
Product Name: ACETYL- L- CARNITINE
Product Code: ST200
INN or Proposed INN: Acetylcarnitine
SIGMA-TAUNULLNot RecruitingFemale: yes
Male: yes
40Italy